The researchers also analyzed records to match the 15,000-plus GLP-1 users to a control group, matching the groups across age, race, ethnicity, body mass index, breast density and diabetes status and finding that those who had been prescribed GLP-1 drugs at Penn Medicine were 30.5% less likely to be diagnosed with breast cancer
4 and Table S3)
Biagi E, Rousseau R, Yvon E, Schwartz M, Dotti G, Foster A, Havlik-Cooper D, Grilley B, Gee A, Baker K, Carrum G, Rice L, Andreeff M , Popat U, Brenner M
in Medical Biochemistry Ch
These findings suggest a potential link between OS, pathological calcium signaling, mitochondrial dysfunction, and the amplification of inflammation in canine pancreatitis through ROS
Melanosis colon itself is benign and does not increase the risk of cancer